Drake, C. G., Pachynski, R. K., Subudhi, S. K., McNeel, D. G., Antonarakis, E. S., Bauer, T. M., Lauer, P., Brockstedt, D., Patricia, D., Wade, M., Zudaire, E., Bandyopadhyay, N., Parasrampuria, D. A., Girgis, S., Mason, G. E., Knoblauch, R. E., Stone, N., Infante, J. R., Gottardis, M. M., & Fong, L. (2021). Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancer. Prostate Cancer and Prostatic Diseases, 25(2), 219–228. https://doi.org/10.1038/s41391-021-00402-8